Nurx Tirzepatide Review: Cost & Honest Verdict (2026)

Nurx is an established women's telehealth brand offering tiered GLP-1 weight-loss programs, but the ranking's own research found very limited public information about its specific tirzepatide program details. Every fact here comes from the company's own published program.

What Nurx is

Nurx is an established women's telehealth brand, offering both compounded semaglutide and tirzepatide as tiered weight-loss programs.

What Nurx costs

Tirzepatide starts around $179/month at the starting dose, though Nurx does not publish a price until after the intake — the ranking's research found only this starting figure, with limited further detail on the site's public pages.

The brand-vs-compounded question

Nurx dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Nurx's real strengths is an established brand name in women's telehealth, and both semaglutide and tirzepatide available with compounded GLP-1 access. The trade-off is significant, and this review flags it directly: very limited public information on program specifics — pricing isn't published until after intake, and details on pharmacy sourcing, accreditation, and state coverage aren't readily available on public pages. As with any GLP-1 program, and especially one this thin on public disclosure, ask directly about pharmacy sourcing and your actual price before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Nurx's brand recognition is a real asset, but this review found very little public detail on its specific tirzepatide program — ask directly before committing. For a women-focused provider with fuller public disclosure, compare it against Nalena or NuBloom. See our best tirzepatide providers ranking for the full field.